Pretreatment Proteinuria Predicts the Prognosis of Patients Receiving Systemic Therapy for Unresectable Hepatocellular Carcinoma

SIMPLE SUMMARY: Proteinuria is a common adverse event of systemic therapy for hepatocellular carcinoma (HCC); however, its effect on clinical outcomes is not well understood. A retrospective analysis of 321 patients with unresectable HCC who received systemic therapy as first-line treatment was perf...

Descripción completa

Detalles Bibliográficos
Autores principales: Mizuno, Kazuyuki, Imai, Norihiro, Yamamoto, Takafumi, Yokoyama, Shinya, Yamamoto, Kenta, Ito, Takanori, Ishizu, Yoji, Honda, Takashi, Kuzuya, Teiji, Ishigami, Masatoshi, Kawashima, Hiroki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10216745/
https://www.ncbi.nlm.nih.gov/pubmed/37345189
http://dx.doi.org/10.3390/cancers15102853

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10216745/
https://www.ncbi.nlm.nih.gov/pubmed/37345189
http://dx.doi.org/10.3390/cancers15102853

Ejemplares similares